MeSH D018442 - b-cell lymphoma marginal zone
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| TG Therapeutics | Umbralisib | Ukoniq | 2033-07-02 | 2021-02-05 |
Clinical Trials
Historical Success Rate
Phase 1
65%46/71
Phase 2
3%2/80
Phase 3
29%2/7
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use